Skip to content

BIOTECH BELGIUM

Active
Private limited companyfounded 2005active for 21 yearsRue des Tanneurs 47, 4500 Huy, BelgiumKBO/BCE: BE 0872.514.604
Summary

BIOTECH BELGIUM has been active since 2005 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €32,017 and a net result of €1,913. Equity has been growing by about 9.6% per year since 2018. Its solvency ranks better than 83% of 17,119 sector peers (NACE 68, financial year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).

Overview

Official details

Source: KBO
Status
Active since 15-03-2005 Normal situation
Activity
Renting and operating of own or leased residential real estate, excluding social housing NACE 68201and 5 others
Establishment unit
2.146.238.034 4500 Huy, since 10-03-2005
Financial year end
31 December
Peppol
Reachable since 18-03-2026

Board and ownership

Board

Financial position

87 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.3%
Annual accounts 2025
Gross margin
€29,328
▲ 440%
Turnover
≈ €48,000
estimated
Profit
€1,913
▼ 37.4%
Equity
€32,017
▲ 6.4%
Total assets
€42,133
▲ 16.8%
Filed on 08-05-2026, 84 days before the deadline
Score breakdownraises risk1 change of registered office in 24 monthsSize: total assets €42,133lowers riskLiquidity: current ratio 4.17, cash €6,122Sector: Real estate activities (NACE 68)Show the evidence

Checked score

Score 2025
87 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 66% of micro companies in real estate (NACE 68)
Financial strength · tick: 2024
Strong
Solvency 100=
equity 76.0% of total assets
Liquidity 59-18
short-term debt 24.0% · cash 14.5%
Profitability 49-10
return on assets 4.5%
Bankruptcy probability within 12 months
0.3% Very low
0%0.5%1.5%4%10%≥ 25%

About 3 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.2% (26,625 companies, NACE 68, micro)
Last 24 months 12-2024: 0.3% 01-2025: 0.3%● unchanged vs 12-2024 02-2025: 0.3%● unchanged vs 01-2025 03-2025: 0.3%● unchanged vs 02-2025 04-2025: 0.3%● unchanged vs 03-2025 05-2025: 0.3%● unchanged vs 04-2025 06-2025: 0.3%● unchanged vs 05-2025 07-2025: 0.4%▲ +0.1 percentage points vs 06-2025highest value 08-2025: 0.1%▼ -0.3 percentage points vs 07-2025 09-2025: 0.1%● unchanged vs 08-2025 10-2025: 0.1%● unchanged vs 09-2025 11-2025: 0.1%● unchanged vs 10-2025 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025lowest value 02-2026: 0.1%● unchanged vs 01-2026lowest value 03-2026: 0.1%● unchanged vs 02-2026 04-2026: 0.3%▲ +0.2 percentage points vs 03-2026 05-2026: 0.3%● unchanged vs 04-2026 06-2026: 0.3%● unchanged vs 05-2026 07-2026: 0.3%● unchanged vs 06-2026 08-2026: 0.3%● unchanged vs 07-2026 09-2026: 0.3%● unchanged vs 08-2026 10-2026: 0.3%● unchanged vs 09-2026 11-2026: 0.3%● unchanged vs 10-2026
Credit of up to €2,500 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 4.17 (6.05 in 2024), above the usual 1.5. Short-term debt is 24% and cash 14.5% of total assets. 24% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 68, micro). It does better than 91% of them on solvency, 71% on liquidity, 42% on profitability and 61% on growth.

The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises riskneutral
raises risk · 1 change of registered office in 24 months
Belgian Official Gazette
raises risk · Size: total assets €42,133
Companies of this size fail more often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Liquidity: current ratio 4.17, cash €6,122
NBB · annual accounts
lowers risk · Sector: Real estate activities (NACE 68)
KBO
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 08-05-2026, 84 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
84 days early
2024
9 days early
2023
47 days early
2022
49 days late
2021
94 days late
2020
101 days late
2019
117 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 32 days after the deadline. In the sector (NACE 68), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 22 July (4 of the last 5 accounts filed within 75 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Caution: Board changedlatest change 09-03-2026 · 1 in office 1 joined · 1 left View
  • Positive: Higher solvency than 83% of companies in real estatesector median 29.0% · 17,119 companies 76.0% View

Recent changes

  1. · Gazette deed Resignation: Yves Delacroix (director)Appointment: Mathieu Eeckhout (sole director)
  2. · Gazette deed Resignation: Yves DELACROIX (sole director)Reappointment: Yves DELACROIX (sole director) · Permanent representative: Yves DELACROIX
  3. · Gazette deed Incorporation
All 17 events

Comparable companies

These companies have the same main activity as BIOTECH BELGIUM: renting and operating of own or leased residential real estate, excluding social housing (NACE 68201). They are comparable in size and age: total assets between €31,400 and €67,100, founded between 1999 and 2010.

CompanyTotal assetsGross margin
BIOTECH BELGIUM Huy€42,133€29,328
REALM() Nijlen€61,292€25,841
BELGIUM HOUSING RENTING Namur€31,405€20,953
CHATEAU DE RESTEIGNE Tellin€40,383€46,856
J.D. IMMO SERVICES Morlanwelz€67,083€31,857
IMMOBILIERE SOCIALE DU PARC Sint-Gillis (bij-Brussel)€32,554€19,518
REART Lasne€62,550€26,893
Full comparison

Key facts about BIOTECH BELGIUM

What is the company number of BIOTECH BELGIUM?
The company number of BIOTECH BELGIUM is 0872.514.604. The VAT number is the same number with BE in front: BE 0872.514.604.
Where is BIOTECH BELGIUM based?
The registered office is at Rue des Tanneurs 47, 4500 Huy.Company details
What does BIOTECH BELGIUM do?
According to the KBO register, the main activity is renting and operating of own or leased residential real estate, excluding social housing (NACE 68201).
What is the legal form of BIOTECH BELGIUM?
The legal form of BIOTECH BELGIUM is Private limited company (BV).
When was BIOTECH BELGIUM founded?
BIOTECH BELGIUM was founded on 15-03-2005.
Is BIOTECH BELGIUM still active?
Yes, BIOTECH BELGIUM is an active enterprise in the KBO register.
What is the turnover of BIOTECH BELGIUM?
The turnover in financial year 2025 is ≈ €48,000. This figure is estimated from the gross margin of €29,328 and 51 comparable companies (NACE 682). It probably lies between €36,000 and €70,000.Financials
Is BIOTECH BELGIUM profitable?
In financial year 2025, BIOTECH BELGIUM made a profit of €1,913.
Where can I find the annual accounts of BIOTECH BELGIUM?
BIOTECH BELGIUM filed 19 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of BIOTECH BELGIUM due?
BIOTECH BELGIUM must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.